Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

MC Müller, N Gattermann, T Lahaye, MWN Deininger… - Leukemia, 2003 - nature.com
We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with
chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive …
被引用次数：173 相关文章

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C

MC Muller, N Gattermann, T Lahaye, MW Deininger… - Leukemia, 2003 - eprints.soton.ac.uk
We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with
chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive …

[引用][C] Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

MC Müller, N Gattermann, T Lahaye, MWN Deininger… - Leukemia, 2003 - cir.nii.ac.jp
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous
leukemia patients with imatinib or interferon α/ara-C | CiNii Research CiNii 国立情報学 …

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.

MC Müller, N Gattermann, T Lahaye, MW Deininger… - Leukemia, 2003 - europepmc.org
We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with
chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive …
[PDF] researchgate.net

[PDF][PDF] Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon a/ara-C

MC Müller, N Gattermann, T Lahaye, MWN Deininger… - Leukemia, 2003 - researchgate.net
We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with
chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive …

[引用][C] Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

MC MÜLLER, N GATTERMANN, SW KRAUSE… - …, 2003 - pascal-francis.inist.fr
Author MÜLLER, M. C 1; GATTERMANN, N 2; KRAUSE, S. W 10; NERL, C 11; SAYER, H. G
12; OTTMANN, O. G 13; WALLER, C 14; AULITZKY, W 15; LE COUTRE, P 16; FREUND, M …

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.

MC Müller, N Gattermann, T Lahaye, MW Deininger… - 2003 - mediatum.ub.tum.de
We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with
chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive …

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon a/ara-C.

MC Müller, N Gattermann, T Lahaye… - Leukemia …, 2003 - search.ebscohost.com
We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with
chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive …

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C

MC Müller, N Gattermann, T Lahaye… - …, 2003 - pubmed.ncbi.nlm.nih.gov
We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with
chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive …

[引用][C] Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

MC MÜLLER, N GATTERMANN, T LAHAYE… - …, 2003 - Nature Publishing Group